MA38174A1 - Souche de bifidobacterium animalis ssp. Animalis - Google Patents

Souche de bifidobacterium animalis ssp. Animalis

Info

Publication number
MA38174A1
MA38174A1 MA38174A MA38174A MA38174A1 MA 38174 A1 MA38174 A1 MA 38174A1 MA 38174 A MA38174 A MA 38174A MA 38174 A MA38174 A MA 38174A MA 38174 A1 MA38174 A1 MA 38174A1
Authority
MA
Morocco
Prior art keywords
animalis
strain
ssp
bifidobacterium
new strain
Prior art date
Application number
MA38174A
Other languages
English (en)
Inventor
Sophie Legrain-Raspaud
Gianfranco Grompone
Sandrine Capronnier
Tamara Smokvina
Marie-Christine Degivry
Biliana Lesic
Michel Neunlist
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of MA38174A1 publication Critical patent/MA38174A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une nouvelle souche de bifidobacterium animalis ssp. Animalis, qui est capable, entre autres, d'améliorer la fonction du système nerveux entérique, et des compositions comprenant ladite nouvelle souche.
MA38174A 2012-12-18 2013-12-10 Souche de bifidobacterium animalis ssp. Animalis MA38174A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2012/057431 WO2014096901A1 (fr) 2012-12-18 2012-12-18 Souche de bifidobacterium animalis ssp. animalis
PCT/IB2013/060774 WO2014097050A1 (fr) 2012-12-18 2013-12-10 Souche de bifidobacterium animalis ssp. animalis

Publications (1)

Publication Number Publication Date
MA38174A1 true MA38174A1 (fr) 2018-03-30

Family

ID=47633132

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38174A MA38174A1 (fr) 2012-12-18 2013-12-10 Souche de bifidobacterium animalis ssp. Animalis

Country Status (17)

Country Link
US (1) US10064902B2 (fr)
EP (1) EP2934557B1 (fr)
JP (1) JP6197045B2 (fr)
KR (1) KR102146429B1 (fr)
CN (1) CN105025907B (fr)
AR (1) AR093916A1 (fr)
CA (1) CA2893822C (fr)
EA (1) EA030356B1 (fr)
ES (1) ES2621264T3 (fr)
HU (1) HUE032210T2 (fr)
MA (1) MA38174A1 (fr)
MX (1) MX358026B (fr)
PL (1) PL2934557T3 (fr)
PT (1) PT2934557T (fr)
TN (1) TN2015000259A1 (fr)
WO (2) WO2014096901A1 (fr)
ZA (1) ZA201504217B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3285785B1 (fr) 2015-04-23 2024-02-21 Compagnie Gervais Danone Composition de réduction de production de gaz intestinaux
WO2017021754A1 (fr) * 2015-07-31 2017-02-09 Compagnie Gervais Danone Procédés de préparation de produits fermentés comprenant des bifidobactéries
KR101910808B1 (ko) * 2016-11-28 2018-10-24 주식회사 쎌바이오텍 유산균 유래 p8 단백질 및 이의 항암 용도
CN107574133A (zh) * 2017-05-05 2018-01-12 南昌大学 动物双歧杆菌m2017064及其在缓解慢性肾脏疾病药物的应用
KR101964883B1 (ko) 2017-10-26 2019-04-02 서울대학교 산학협력단 한국 유아 분변 유래의 베타-갈락토시데이즈 활성이 우수한 신규 균주 비피도박테리움 애니멀리스 ldtm8101
KR102238519B1 (ko) * 2018-12-28 2021-04-13 (주)메디톡스 외래 단백질을 발현하는 미생물, 및 그의 용도
CA3145236C (fr) * 2019-06-27 2024-03-26 Il Dong Pharmaceutical Co., Ltd. Nouvelle composition probiotique pour la regulation de l'immunite intestinale
CN111826299B (zh) * 2020-01-22 2022-06-21 内蒙古蒙牛乳业（集团）股份有限公司 一种润肠通便的乳双歧杆菌及其应用与制剂
KR20210129516A (ko) * 2020-04-20 2021-10-28 주식회사 리비옴 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도
CN112159778B (zh) * 2020-09-30 2021-12-03 江南大学 一株可缓解银屑病的动物双歧杆菌及其应用
CN114717132B (zh) * 2021-09-08 2023-07-07 青岛蔚蓝生物股份有限公司 一株具有预防和缓解便秘症状的乳双歧杆菌及其应用
KR102495386B1 (ko) * 2021-12-08 2023-02-06 ㈜새롬바이오 유산균을 이용한 저글루텐 밀가루 발효조성물, 이를 포함하는 식품첨가제 및 이를 포함하는 식품, 및 그 제조 방법
CN114350577B (zh) * 2022-03-17 2022-05-27 微康益生菌(苏州)股份有限公司 一种改善便秘的动物双歧杆菌乳亚种BLa36及其培养方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020044046A (ko) * 2001-07-30 2002-06-14 비앤아이티(주) 복합 생균제를 소재로 한 장기능 개선용 건강기능성식품
EP1384483A1 (fr) * 2002-07-23 2004-01-28 Nestec S.A. Microorganismes probiotiques pour le traitement du syndrome du colon irritabile par l'amélioration de la fonction neuro-musculaire de l'intestin
WO2010008272A1 (fr) * 2008-07-15 2010-01-21 N.V. Nutricia Traitement de troubles du transit intestinal
DK2403510T3 (da) * 2009-03-05 2020-03-23 Probiotical Spa Bakteriestammer med en høj antiinflammatorisk aktivitet
US8685388B2 (en) * 2009-11-02 2014-04-01 Compagnie Gervais Danone Method for reducing gastro-intestinal inflammation using Bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria
ES2437940T3 (es) * 2010-01-28 2014-01-15 Ab-Biotics S.A. Composición probiótica para uso en el tratamiento de la inflamación del intestino
WO2011148219A1 (fr) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Souches probiotiques destinées à être utilisées dans l'amélioration du système nerveux entérique
WO2011148220A1 (fr) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Souches probiotiques pour l'utilisation dans l'amélioration de la résistance transépithéliale

Also Published As

Publication number Publication date
KR20150095717A (ko) 2015-08-21
US20150320807A1 (en) 2015-11-12
EP2934557B1 (fr) 2017-01-04
JP6197045B2 (ja) 2017-09-13
US10064902B2 (en) 2018-09-04
ZA201504217B (en) 2017-08-30
CA2893822A1 (fr) 2014-06-26
MX2015007814A (es) 2015-08-20
WO2014097050A9 (fr) 2014-11-06
CN105025907A (zh) 2015-11-04
EA201591057A1 (ru) 2015-10-30
HUE032210T2 (hu) 2017-09-28
ES2621264T3 (es) 2017-07-03
WO2014097050A1 (fr) 2014-06-26
EA030356B1 (ru) 2018-07-31
TN2015000259A1 (en) 2016-10-03
CA2893822C (fr) 2021-09-21
WO2014096901A1 (fr) 2014-06-26
CN105025907B (zh) 2019-05-31
AR093916A1 (es) 2015-06-24
PT2934557T (pt) 2017-04-05
PL2934557T3 (pl) 2017-08-31
JP2016502842A (ja) 2016-02-01
EP2934557A1 (fr) 2015-10-28
MX358026B (es) 2018-08-02
KR102146429B1 (ko) 2020-08-20

Similar Documents

Publication Publication Date Title
MA38174A1 (fr) Souche de bifidobacterium animalis ssp. Animalis
MA38143A1 (fr) Composition comprenant des agents de lutte biologique
MA47664B1 (fr) Anticorps anti-c10orf54 et leurs utilisations
EA201391597A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
MA35712B1 (fr) Anticorps anti-htra1 et leurs procédés d'utilisation
NO20083850L (no) Fosfolipidkomplekser av cirkumin med forbedret biotilgjengelighet
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
MX360499B (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
EA201170396A1 (ru) 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
MA37538A2 (fr) Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
MA35898B1 (fr) Anticorps anti-lrp5 et leurs procédés d'utilisation
PH12018502580A1 (en) Formulations for paddy rice fields
MA38526A1 (fr) Nouvelle souche bactérienne de lysobacter capsici et ses utilisations
BR112015009287A2 (pt) biocontrole de nematódeos
FI20115374A0 (fi) Uudet hypoallergeenit
EA201400881A1 (ru) Полиморфы n-(2-метоксибензоил)-4-[(метиламинокарбонил)амино]бензолсульфонамида
EA201591725A1 (ru) Твердые липидные наночастицы (ii)
UA111663C2 (uk) Газопродувний елемент і співвіднесений газопідвідний трубопровід
IN2014MN02254A (fr)
EA201791437A1 (ru) Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы
FR3082207B1 (fr) Nouvelle souche probiotique de lactobacillus brevis
EA201591444A1 (ru) Мутированные гены алленоксидсинтазы 2 (aos2)
MY174744A (en) Uses of bacopa monnieri extract
IN2015DN02699A (fr)